Max Healthcare, Apollo Hospitals, Sun Pharma, Dr Reddy’s: Stocks in focus as NPPA caps cancer drug margins
The measure, effective November 9, 2026, is expected to reduce the maximum retail prices (MRPs) of the affected medicines by up to 70%, depending on their existing price structures.
The measure, effective November 9, 2026, is expected to reduce the maximum retail prices (MRPs) of the affected medicines by up to 70%, depending on their existing price structures.
What's Your Reaction?
